1
|
Folkesson J, Birgisson H, Pahlman L,
Cedermark B, Glimelius B and Gunnarsson U: Swedish rectal cancer
trial: Long lasting benefits from radiotherapy on survival and
local recurrence rate. J Clin Oncol. 23:5644–5650. 2005.PubMed/NCBI View Article : Google Scholar
|
2
|
Peeters KC, Marijnen CA, Nagtegaal ID,
Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius
B, Leer JW, et al: The TME trial after a median follow-up of 6
years: Increased local control but no survival benefit in
irradiated patients with resectable rectal carcinoma. Ann Surg.
246:693–701. 2007.PubMed/NCBI View Article : Google Scholar
|
3
|
Bosset JF, Collette L, Calais G, Mineur L,
Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A and Ollier
JC: EORTC Radiotherapy Group Trial 22921. Chemotherapy with
preoperative radiotherapy in rectal cancer. N Engl J Med.
355:1114–1123. 2006.PubMed/NCBI View Article : Google Scholar
|
4
|
Topova L, Hellmich G, Puffer E, Schubert
C, Christen N, Boldt T, Wiedemann B, Witzigmann H and Stelzner S:
Prognostic value of tumor response to neoadjuvant therapy in rectal
carcinoma. Dis Colon Rectum. 54:401–411. 2011.PubMed/NCBI View Article : Google Scholar
|
5
|
Tomono A, Yamashita K, Kanemitsu K, Sumi
Y, Yamamoto M, Kanaji S, Imanishi T, Nakamura T, Suzuki S, Tanaka K
and Kakeji Y: Prognostic significance of pathological response to
preoperative chemoradiotherapy in patients with locally advanced
rectal cancer. Int J Clin Oncol. 21:344–349. 2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Tada N, Kawai K, Tsuno NH, Ishihara S,
Yamaguchi H, Sunami E, Kitayama J, Oba K and Watanabe T: Prediction
of the preoperative chemoradiotherapy response for rectal cancer by
peripheral blood lymphocyte subsets. World J Surg Oncol.
13(30)2015.PubMed/NCBI View Article : Google Scholar
|
7
|
Ishihara S, Iinuma H, Fukushima Y, Akahane
T, Horiuchi A, Shimada R, Shibuya H, Hayama T, Yamada H, Nozawa K,
et al: Radiation-induced apoptosis of peripheral blood lymphocytes
is correlated with histological regression of rectal cancer in
response to preoperative chemoradiotherapy. Ann Surg Oncol.
19:1192–1198. 2012.PubMed/NCBI View Article : Google Scholar
|
8
|
Shinto E, Hase K, Hashiguchi Y, Sekizawa
A, Ueno H, Shikina A, Kajiwara Y, Kobayashi H, Ishiguro M and
Yamamoto J: CD8+ and FOXP3+ tumor-infiltrating T cells before and
after chemoradiotherapy for rectal cancer. Ann Surg Oncol. 21
(Suppl 3):S414–S421. 2014.PubMed/NCBI View Article : Google Scholar
|
9
|
Yasuda K, Nirei T, Sunami E, Nagawa H and
Kitayama J: Density of CD4(+) and CD8(+) T lymphocytes in biopsy
samples can be a predictor of pathological response to
chemoradiotherapy (CRT) for rectal cancer. Radiat Oncol.
6(49)2011.PubMed/NCBI View Article : Google Scholar
|
10
|
McCoy MJ, Hemmings C, Miller TJ, Austin
SJ, Bulsara MK, Zeps N, Nowak AK, Lake RA and Platell CF: Low
stromal Foxp3+ regulatory T-cell density is associated with
complete response to neoadjuvant chemoradiotherapy in rectal
cancer. Br J Cancer. 113:1677–1686. 2015.PubMed/NCBI View Article : Google Scholar
|
11
|
Teng F, Meng X, Kong L, Mu D, Zhu H, Liu
S, Zhang J and Yu J: Tumor-infiltrating lymphocytes, forkhead box
P3, programmed death ligand-1, and cytotoxic T
lymphocyte-associated antigen-4 expressions before and after
neoadjuvant chemoradiation in rectal cancer. Transl Res.
166:721–732.e1. 2015.PubMed/NCBI View Article : Google Scholar
|
12
|
Anitei MG, Zeitoun G, Mlecnik B, Marliot
F, Haicheur N, Todosi AM, Kirilovsky A, Lagorce C, Bindea G,
Ferariu D, et al: Prognostic and predictive values of the
immunoscore in patients with rectal cancer. Clin Cancer Res.
20:1891–1899. 2014.PubMed/NCBI View Article : Google Scholar
|
13
|
Taylor MR, Couto JR, Scallan CD, Ceriani
RL and Peterson JA: Lactadherin (formerly BA46), a
membrane-associated glycoprotein expressed in human milk and breast
carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion. DNA
Cell Biol. 16:861–869. 1997.PubMed/NCBI View Article : Google Scholar
|
14
|
Hanayama R, Tanaka M, Miwa K, Shinohara A,
Iwamatsu A and Nagata S: Identification of a factor that links
apoptotic cells to phagocytes. Nature. 417:182–187. 2002.PubMed/NCBI View
Article : Google Scholar
|
15
|
Miyasaka K, Hanayama R, Tanaka M and
Nagata S: Expression of milk fat globule epidermal growth factor 8
in immature dendritic cells for engulfment of apoptotic cells. Eur
J Immunol. 34:1414–1422. 2004.PubMed/NCBI View Article : Google Scholar
|
16
|
Li BZ, Zhang HY, Pan HF and Ye DQ:
Identification of MFG-E8 as a novel therapeutic target for
diseases. Expert Opin Ther Targets. 17:1275–1285. 2013.PubMed/NCBI View Article : Google Scholar
|
17
|
Jinushi M, Nakazaki Y, Dougan M, Carrasco
DR, Mihm M and Dranoff G: MFG-E8-mediated uptake of apoptotic cells
by APCs links the pro- and antiinflammatory activities of GM-CSF. J
Clin Invest. 117:1902–1913. 2007.PubMed/NCBI View Article : Google Scholar
|
18
|
Tibaldi L, Leyman S, Nicolas A, Notebaert
S, Dewulf M, Ngo TH, Zuany-Amorim C, Amzallag N, Bernard-Pierrot I,
Sastre-Garau X and Théry C: New blocking antibodies impede
adhesion, migration and survival of ovarian cancer cells,
highlighting MFGE8 as a potential therapeutic target of human
ovarian carcinoma. PLoS One. 8(e72708)2013.PubMed/NCBI View Article : Google Scholar
|
19
|
Sugano G, Bernard-Pierrot I, Laé M,
Battail C, Allory Y, Stransky N, Krumeich S, Lepage ML, Maille P,
Donnadieu MH, et al: Milk fat globule-epidermal growth
factor-factor VIII (MFGE8)/lactadherin promotes bladder tumor
development. Oncogene. 30:642–653. 2011.PubMed/NCBI View Article : Google Scholar
|
20
|
Soki FN, Koh AJ, Jones JD, Kim YW, Dai J,
Keller ET, Pienta KJ, Atabai K, Roca H and McCauley LK:
Polarization of prostate cancer-associated macrophages is induced
by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis. J
Biol Chem. 289:24560–24572. 2014.PubMed/NCBI View Article : Google Scholar
|
21
|
Oba J, Moroi Y, Nakahara T, Abe T,
Hagihara A and Furue M: Expression of milk fat globule epidermal
growth factor-VIII may be an indicator of poor prognosis in
malignant melanoma. Br J Dermatol. 165:506–512. 2011.PubMed/NCBI View Article : Google Scholar
|
22
|
Zhao Q, Xu L, Sun X, Zhang K, Shen H, Tian
Y, Sun F and Li Y: MFG-E8 overexpression promotes colorectal cancer
progression via AKT/MMPs signalling. Tumour Biol.
39(1010428317707881)2017.PubMed/NCBI View Article : Google Scholar
|
23
|
Kusunoki R, Ishihara S, Tada Y, Oka A,
Sonoyama H, Fukuba N, Oshima N, Moriyama I, Yuki T, Kawashima K, et
al: Role of milk fat globule-epidermal growth factor 8 in colonic
inflammation and carcinogenesis. J Gastroenterol. 50:862–875.
2015.PubMed/NCBI View Article : Google Scholar
|
24
|
Brierley JD, Gospodarowicz MK and
Wittekind C (eds): The TNM classification of malignant tumours, 8th
edition. Wiley Blackwell, Oxford, 2017.
|
25
|
Japanese classification of colorectal
carcinoma. Kanehara & Co., Ltd., Tokyo, 2018.
|
26
|
Kanemura T, Miyata H, Makino T, Tanaka K,
Sugimura K, Hamada-Uematsu M, Mizote Y, Uchida H, Miyazaki Y,
Takahashi T, et al: Immunoregulatory influence of abundant MFG-E8
expression by esophageal cancer treated with chemotherapy. Cancer
Sci. 109:3393–3402. 2018.PubMed/NCBI View Article : Google Scholar
|
27
|
Crane CH, Skibber JM, Feig BW, Vauthey JN,
Thames HD, Curley SA, Rodriguez-Bigas MA, Wolff RA, Ellis LM,
Delclos ME, et al: Response to preoperative chemoradiation
increases the use of sphincter-preserving surgery in patients with
locally advanced low rectal carcinoma. Cancer. 97:517–524.
2003.PubMed/NCBI View Article : Google Scholar
|
28
|
Habr-Gama A, Perez RO, Proscurshim I,
Campos FG, Nadalin W, Kiss D and Gama-Rodrigues J: Patterns of
failure and survival for nonoperative treatment of stage c0 distal
rectal cancer following neoadjuvant chemoradiation therapy. J
Gastrointest Surg. 10:1319–1329. 2006.PubMed/NCBI View Article : Google Scholar
|
29
|
Yu CS, Yun HR, Shin EJ, Lee KY, Kim NK,
Lim SB, Oh ST, Kang SB, Choi WJ, Lee WY, et al: Local excision
after neoadjuvant chemoradiation therapy in advanced rectal cancer:
A national multicenter analysis. Am J Surg. 206:482–487.
2013.PubMed/NCBI View Article : Google Scholar
|
30
|
McCoy MJ, Hemmings C, Anyaegbu CC, Austin
SJ, Lee-Pullen TF, Miller TJ, Bulsara MK, Zeps N, Nowak AK, Lake RA
and Platell CF: Tumour-infiltrating regulatory T cell density
before neoadjuvant chemoradiotherapy for rectal cancer does not
predict treatment response. Oncotarget. 8:19803–19813.
2017.PubMed/NCBI View Article : Google Scholar
|
31
|
Jinushi M, Sato M, Kanamoto A, Itoh A,
Nagai S, Koyasu S, Dranoff G and Tahara H: Milk fat globule
epidermal growth factor-8 blockade triggers tumor destruction
through coordinated cell-autonomous and immune-mediated mechanisms.
J Exp Med. 206:1317–1326. 2009.PubMed/NCBI View Article : Google Scholar
|
32
|
Cani PD, Amar J, Iglesias MA, Poggi M,
Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et
al: Metabolic endotoxemia initiates obesity and insulin resistance.
Diabetes. 56:1761–1772. 2007.PubMed/NCBI View Article : Google Scholar
|
33
|
Yang L, Francois F and Pei Z: Molecular
pathways: Pathogenesis and clinical implications of microbiome
alteration in esophagitis and Barrett esophagus. Clin Cancer Res.
18:2138–2144. 2012.PubMed/NCBI View Article : Google Scholar
|
34
|
Meng C, Bai C, Brown TD, Hood LE and Tian
Q: Human gut microbiota and gastrointestinal cancer. Genomics
Proteomics Bioinformatics. 16:33–49. 2018.PubMed/NCBI View Article : Google Scholar
|
35
|
Ladoire S, Martin F and Ghiringhelli F:
Prognostic role of FOXP3+ regulatory T cells infiltrating human
carcinomas: The paradox of colorectal cancer. Cancer Immunol
Immunother. 60:909–918. 2011.PubMed/NCBI View Article : Google Scholar
|
36
|
Canani RB, Costanzo MD, Leone L, Pedata M,
Meli R and Calignano A: Potential beneficial effects of butyrate in
intestinal and extraintestinal diseases. World J Gastroenterol.
17:1519–1528. 2011.PubMed/NCBI View Article : Google Scholar
|
37
|
González-Sarrías A, Giménez-Bastida JA,
Núñez-Sánchez MÁ, Larrosa M, García-Conesa MT, Tomás-Barberán FA
and Espín JC: Phase-II metabolism limits the antiproliferative
activity of urolithins in human colon cancer cells. Eur J Nutr.
53:853–864. 2014.PubMed/NCBI View Article : Google Scholar
|
38
|
Jinushi M, Nakazaki Y, Carrasco DR,
Draganov D, Souders N, Johnson M, Mihm MC and Dranoff G: Milk fat
globule EGF-8 promotes melanoma progression through coordinated Akt
and twist signaling in the tumor microenvironment. Cancer Res.
68:8889–8898. 2008.PubMed/NCBI View Article : Google Scholar
|
39
|
Kong JC, Guerra GR, Pham T, Mitchell C,
Lynch AC, Warrier SK, Ramsay RG and Heriot AG: Prognostic impact of
tumor-infiltrating lymphocytes in primary and metastatic colorectal
cancer: A Systematic review and meta-analysis. Dis Colon Rectum.
62:498–508. 2019.PubMed/NCBI View Article : Google Scholar
|